Philippe, H. Jais Email and Phone Number
Molecular geneticist, medical doctor and scientific head of Eukarÿs, which has developed the first ever artificial expression system able to synthesize in vivo autonomously messenger RNA (mRNA) and consequently the protein of interest in mammalian and other eukaryotic cells. Using the C3P3 system, we aim to revolutionize the production processes of innovative medicines by radically reducing their production costs. We offer Pharma/Biotech, CDMO and academic institutions a range of tools based on the C3P3 system for research and industrial production enabling the high-yield production in mammalian cells of innovative protein-based drugs, such as vaccines, viral vectors for gene therapy and monoclonal antibodies.
-
President And Chief Scientific OfficerEukarÿs SasÎle-De-France, France
-
President & Chief Scientific OfficerEukarÿs Sas Jan 2012 - PresentÉvry, Ile-De-France, FrEukarÿs has developed the first ever artificial expression system able to synthesize in vivo autonomously messenger RNA (mRNA) and consequently the protein of interest in mammalian and other eukaryotic cells. Using the C3P3 system, Eukarÿs develop the unique synthetic gene therapy approach, which is a non-viral, safe, non-integrative, efficient, cost-effective, well-tolerated approach to treat human monogenic and multifactorial disorders. The same C3P3 system is also used for the development of novel cellular tools for the bioproduction of recombinant proteins and viruses. -
Membre Du Comité D'InvestissementSatt Nord Jan 2015 - PresentLille, Fr -
Director Of Clinical Research And Translational MedicineAzurrx Biopharma Oct 2014 - Aug 2017Boca Raton, Fl, Us -
Director Of Clinical Research And Translational MedicineProteabio Jan 2012 - Sep 2014
-
Scientific DirectorHoffmann-La Roche Jan 2010 - Dec 2011Switzerland 🇨🇭 , Ch -
Principal Expert, BiomarkersAbbott Laboratories May 2009 - Dec 2009Abbott Park, Illinois, UsGene expression-based Innovative Medicine approaches for human monogenic disorders, Development of biomarker approaches for diabetic complications -
Principal Expert, BiomarkersSolvay Pharmaceuticals May 2008 - Mar 2009Brussels, BeGene expression-based Innovative Medicine approaches for human monogenic disorders, Development of biomarker approaches for diabetic complications -
Global Program Research DirectorSolvay Pharmaceuticals Jan 2004 - May 2008Brussels, BeEarly development of novel chemical entities including nuclear receptor agonists and other compounds for the treatment of type 2 diabetes and atherosclerosis complications. Special focus on biomarkers including pharmacogenomics, gene expression profiling and other biomarkers
-
Head Of Medical Genetics And PharmacogenomicsGenset Nov 1998 - Dec 2003Team leader for human clinical research. Team leader for pharmacogenomic and genomic programs.
-
Medical Fellow, Molecular And Cellular BiologyAp-Hp, Assistance Publique - Hôpitaux De Paris Nov 1997 - Nov 1998Paris, Île-De-France, FrManagement of team of 2 (post-doc, technician) in charge of research program in the field of Hepatology (investigation of molecular genomic modifications in liver carcinoma affecting apoptosis).Development of diagnosis tools (DGGE, SSCP, dHPLC, DNA methylation profiling and DNA sequencing) for diagnosis of genetically inherited disorder of the liver. Investigation of mechanisms of aptotosis response to hepatic injury (e.g. viral infection or drug hepatotoxicity). -
Phd Candidate In Human Molecular OncogeneticsInstitut Gustave Roussy Oct 1993 - Oct 1996Villejuif, FrSomatic and constitutive molecular oncogenetics of digestive cancers (i.e. familial adenomatous polyposis, hereditary colorectal cancer without polyposis, pancreatic endocrine tumors) -
Medical Fellow, HepatogastroenterologyAssistance Publique- Hopitaux De Paris Oct 1991 - Oct 1994Paris, Île-De-France, FrIn charge of a therapeutic units of and digestive endoscopy unit.
-
Resident, Hepato-GastroenterologyAssistance Publique- Hopitaux De Paris Oct 1984 - Oct 1991Paris, Île-De-France, Fr
Philippe, H. Jais Skills
Philippe, H. Jais Education Details
-
Université Paris Vii, Faculté De Médecine Lariboisière-Saint LouisHepato-Gastroenterology -
Université Paris CitéHuman Molecular Genetics
-
The Johns Hopkins UniversityHuman/Medical Genetics
-
Paris-Sud University (Paris Xi)Biostatistics
-
Lycée Carnot, ParisCollege And High School
Frequently Asked Questions about Philippe, H. Jais
What company does Philippe, H. Jais work for?
Philippe, H. Jais works for Eukarÿs Sas
What is Philippe, H. Jais's role at the current company?
Philippe, H. Jais's current role is President and Chief Scientific Officer.
What schools did Philippe, H. Jais attend?
Philippe, H. Jais attended Université Paris Vii, Faculté De Médecine Lariboisière-Saint Louis, Université Paris Cité, The Johns Hopkins University, Paris-Sud University (Paris Xi), Lycée Carnot, Paris.
What are some of Philippe, H. Jais's interests?
Philippe, H. Jais has interest in Protein Bioproduction, Medicine, Genetics, Research, Genomics, Life Sciences, Biostatistics, Science And Technology, Gene Therapy, Mrna.
What skills is Philippe, H. Jais known for?
Philippe, H. Jais has skills like Genomics, Biotechnology, Biomarkers, Genetics, Clinical Development, Life Sciences, Drug Development, Clinical Research, Lifesciences, Dna Sequencing, Molecular Biology, Translational Medicine.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial